Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence
Key facts
- Who runs it
- University of Maryland, College Park
- Where
- Baltimore and College Park, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 200 people enrolled
- Started
- 5 Apr 2022
- Ended
- 24 Sept 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Peer-Delivered Behavioral Activation ("Peer Activate")
- Record updated
- 27 October 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Initiated methadone at the study site in the past three months (and no less than two weeks prior to study enrollment) or demonstrated challenges with methadone adherence in the past three months as indicated by one or more of the following: a) at least one missing take-home bottle at the time of bottle return; b) screened negative for methadone in routinely administered clinic urinalysis tests; c) transitioned from an extended take-home bottle schedule to daily dosing schedule; or d) at least one missed methadone dose in the past 3 months as identified through clinic records
- Minimum of 18 years old
Who cannot take part
- Demonstrating active, unstable or untreated psychiatric symptoms, including mania and/or psychosis that would interfere with study participation
- Inability to understand the study and provide informed consent in English
- Positive pregnancy status at enrollment
Where in United States
- University of Maryland Baltimore (UMD Drug Treatment Center)Baltimore, United States
- University of Maryland, College ParkCollege Park, United States
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) among low-income, minority individuals living with opioid use disorder (OUD) in Baltimore, Maryland. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this Type 1 hybrid effectiveness-implementation randomized controlled trial (RCT), we will evaluate the effectiveness and implementation of Peer Activate vs. treatment as usual (TAU) over six months.
The 2 groups in the trial
- Peer-Delivered Behavioral Activation ("Peer Activate")Treatment being tested
Participants in the Peer Activate intervention will receive a PRS-delivered behavioral activation intervention to address barriers to retention in methadone treatment and increase substance-free, positive reinforcement to support retention.
- Treatment As UsualNo study treatment, for comparison
Participants in the TAU group will receive treatment as usual (weekly group and individual counseling with an addiction counselor in addition to referral to other available services in the community through study contact).
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Peer-Delivered Behavioral Activation Intervention to Improve Adherence to MT Among Low-Income, Minority Individuals With OUD
- Publications
- Record updated
- 27 October 2025